Lonza and Benitec Enter Agreement to Develop Scalable AAV Manufacturing Process for ddRNAi Therapeutics
Bioprocess InsiderLonza and Benitec Enter Agreement to Develop Scalable AAV Manufacturing Process for ddRNAi TherapeuticsLonza and Benitec Enter Agreement to Develop Scalable AAV Manufacturing Process for ddRNAi Therapeutics
Lonza and Benitec will develop a scalable manufacturing process for Benitec’s ddRNAi-based, Adeno-Associated Virus-delivered products intended for therapeutic use in humans.
Taking Medium and Feed Development Beyond Maximizing Protein Titer to Optimizing Glycan Distribution and Simplifying Process Scale-Up
Sponsored ContentSponsored Content
Sponsored Content